Literature DB >> 10075191

The efficacy of group treatment for survivors of childhood abuse.

E Westbury1, L M Tutty.   

Abstract

OBJECTIVE: To assess the effectiveness of a new model of group treatment for sexual abuse survivors over individual therapy alone.
METHOD: In this quasi-experimental design, 32 women were in either group treatment (N = 22) or a wait-list comparison group (N = 10). They completed standardized measures on depression, self-esteem, and trauma symptomatology at pretest and after completing the 10 to 12 week group. All were in concurrent individual therapy.
RESULTS: On average, both groups of women decreased depression and trauma symptoms as well as increased self-esteem. However, the clients in the treatment group improved their depression and anxiety to a statistically significantly greater degree than clients in the wait-list comparison condition. Improvement approaching statistical significance was found in levels of self-esteem in the treatment as compared to the wait-list condition.
CONCLUSION: The group intervention was significantly more effective than individual treatment alone on depression and anxiety. The inclusion of the wait-list comparison group was critical in interpreting the improvement noted by all of the women in treatment.

Entities:  

Mesh:

Year:  1999        PMID: 10075191     DOI: 10.1016/s0145-2134(98)00109-4

Source DB:  PubMed          Journal:  Child Abuse Negl        ISSN: 0145-2134


  2 in total

Review 1.  The long-term health outcomes of childhood abuse. An overview and a call to action.

Authors:  Kristen W Springer; Jennifer Sheridan; Daphne Kuo; Molly Carnes
Journal:  J Gen Intern Med       Date:  2003-10       Impact factor: 5.128

2.  Interventions for adults with a history of complex traumatic events: the INCiTE mixed-methods systematic review.

Authors:  Hollie Melton; Nick Meader; Holly Dale; Kath Wright; Julie Jones-Diette; Melanie Temple; Iram Shah; Karina Lovell; Dean McMillan; Rachel Churchill; Corrado Barbui; Simon Gilbody; Peter Coventry
Journal:  Health Technol Assess       Date:  2020-09       Impact factor: 4.014

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.